Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sulodexide (VESSEL®) for the Prevention of Recurrent Venous Thromboembolism in Elderly Patients After a First Episode of Venous Thrombembolism

NCT04257487 is registered in ClinicalTrials.gov with Arianna Anticoagulazione Foundation as lead sponsor.

NCT NCT04257487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04257487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sulodexide (VESSEL®) for the Prevention of Recurrent Venous Thromboembolism in Elderly Patients After a First Episode of Venous Thrombembolism
Lead sponsor
Arianna Anticoagulazione Foundation
Phase
Phase 3
Overall status
Recruiting
Start date
December 21, 2020
Completion date
January 2, 2027
Enrollment
1,455 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant, elderly, venous thromboembolism